SecBot SecBot
6-K ·Filed Nov 12, 2026

GMAB

GENMAB A/S
NEUTRAL
Impact 2/10
Horizonimmediate Processed4d 15h ago SEC0001434265-26-000154
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine filing of updated articles of association with no new financial data. Monitor future 6-K filings for earnings releases or material corporate developments.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$51.74
T+0 close · Nov 12, 2026 · via day close
Latest settled
−0.72%
T+1 · $51.37
Vs SPY
−0.35%
α at T+1
Next horizon
T+5
in 2d
  1. T+0 · Nov 12 $51.74entry
  2. T+1 · 4d ago −0.72%α −0.35% · $51.37
  3. T+2 · todayOpen
  4. T+5 · in 2d Pending
  5. T+20 · in 24d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Genmab filed its updated Articles of Association on Form 6-K, reflecting routine governance updates including authorized capital increases for employee warrants and convertible debt instruments. No financial results, guidance, or material operational events were disclosed in this filing.

Key Facts

  • Filed updated Articles of Association dated November 10, 2026
  • Share capital is DKK 62,570,683 divided into shares of DKK 1 each
  • Board authorized until March 12, 2029 to increase share capital by up to DKK 6,600,000 without pre-emption rights
  • Board authorized until March 12, 2029 to issue convertible debt instruments up to DKK 3,000,000 nominal
  • Multiple warrant programs for employees described, with authorizations extending to March 2030
  • No financial results, earnings, or operational updates included

Financial Impact

No financial impact; routine governance filing

Risk Factors

  • No material risks identified from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
80% bullish (25 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001434265-26-000154
Document: gmab_20261112x6kx2.htm0001434265-26-000154
Document: 0001434265-26-000154-index-headers.html0001434265-26-000154
Document: 0001434265-26-000154-index.html0001434265-26-000154
Document: 0001434265-26-000154.txt0001434265-26-000154
Earnings Context (Synthetic; results releases only)0001434265-26-000154

Track record

31 reports on GMAB

Performance horizon

3 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +91.28% at T+60 after the Aug 6, 2026 report. 5 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $52.12 Now $51.57 −1.06% settles Dec 15
  2. Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
  3. Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
  4. Nov 12, 20264d ago 6-K Neutral 2/10 Viewing Entry $51.74 Now $51.57 −0.33% settles Dec 11
  5. Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
  6. Nov 10, 20266d ago 6-K Neutral 2/10 Entry $53.87 Now $51.57 −4.27% settles Dec 10
  7. Nov 10, 20266d ago 144 Neutral 2/10 Entry $54.07 Now $51.57 −4.62% settles Dec 9
  8. Nov 5, 202611d ago 6-K Neutral 5/10 Entry $52.74 Now $51.57 −2.22% settles Dec 4
  9. Nov 4, 202612d ago Institutional Cluster Neutral 2/10 Entry $52.74 Now $51.57 −2.22% settles Dec 4
  10. Oct 28, 202619d ago 6-K Bullish 6/10 Entry $57.29 Now $51.57 −9.98% settles Nov 25
Showing 10 of 31

US Market Status

Market Closed · Opens in 9h 1m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026